- Home
- OMCL vs PEB Comparison
OMCL vs PEB Comparison
Compare OMCL & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- PEB
- Stock Information
- Founded
- OMCL 1992
- PEB 2009
- Country
- OMCL United States
- PEB United States
- Employees
- OMCL N/A
- PEB N/A
- Industry
- OMCL Computer Manufacturing
- PEB Real Estate Investment Trusts
- Sector
- OMCL Technology
- PEB Real Estate
- Exchange
- OMCL Nasdaq
- PEB Nasdaq
- Market Cap
- OMCL 1.5B
- PEB 1.2B
- IPO Year
- OMCL 2001
- PEB 2009
- Fundamental
- Price
- OMCL $32.11
- PEB $11.80
- Analyst Decision
- OMCL Buy
- PEB Hold
- Analyst Count
- OMCL 7
- PEB 7
- Target Price
- OMCL $46.71
- PEB $12.00
- AVG Volume (30 Days)
- OMCL 549.1K
- PEB 2.0M
- Earning Date
- OMCL 10-29-2025
- PEB 11-05-2025
- Dividend Yield
- OMCL N/A
- PEB 0.34%
- EPS Growth
- OMCL N/A
- PEB N/A
- EPS
- OMCL 0.49
- PEB N/A
- Revenue
- OMCL $1,149,529,000.00
- PEB $1,469,933,000.00
- Revenue This Year
- OMCL $5.37
- PEB $1.63
- Revenue Next Year
- OMCL $3.67
- PEB $2.84
- P/E Ratio
- OMCL $67.08
- PEB N/A
- Revenue Growth
- OMCL 6.39
- PEB 2.00
- 52 Week Low
- OMCL $22.66
- PEB $7.42
- 52 Week High
- OMCL $55.75
- PEB $15.12
- Technical
- Relative Strength Index (RSI)
- OMCL 52.90
- PEB 71.28
- Support Level
- OMCL $31.90
- PEB $10.87
- Resistance Level
- OMCL $33.75
- PEB $11.34
- Average True Range (ATR)
- OMCL 0.87
- PEB 0.35
- MACD
- OMCL -0.10
- PEB 0.15
- Stochastic Oscillator
- OMCL 31.95
- PEB 84.22
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.